In vivo use of human bone marrow for investigation and production
US5633426A · kind A · utility
40Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 10, 1994 |
| Grant date | May 27, 1997 |
| Priority date | — |
| Expiry date | Feb 10, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01K67/0271
- WIPO fieldOther special machines
- WIPO sectorMechanical engineering
Abstract
Chimeric immunocompromised hosts are provided, comprising human bone marrow of at least 4 weeks from the time of implantation. The bone marrow is found to assume the normal population of bone marrow except for erythrocytes. The bone marrow may be used to study the effect of various agents on the proliferation and differentiation of hematopoietic cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.